158 results on '"Stein, Sokrates"'
Search Results
2. Inhibition of de novo ceramide synthesis by Sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes
3. The NO-donor MPC-1011 stimulates angiogenesis and arteriogenesis and improves hindlimb ischemia via a cGMP-dependent pathway involving VEGF and SDF-1α
4. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis – Central role of macrophage scavenger receptor 1
5. Additional file 1 of Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion
6. Co-repressing immunometabolic processes in atherosclerosis
7. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease
8. A SIRT7-Dependent Acetylation Switch of GABPβ1 Controls Mitochondrial Function
9. SUMOylation-Dependent LRH-1/PROX1 Interaction Promotes Atherosclerosis by Decreasing Hepatic Reverse Cholesterol Transport
10. Abstract 11798: The Nitric Oxide-Donor MPC-1011 Stimulates Angiogenesis and Arteriogenesis and Improves Hindlimb Ischemia via a cGMP-dependent Pathway Involving VEGF and SDF-1 Alpha
11. Carotid Plaque Composition and the Importance of Non-Invasive in Imaging Stroke Prevention
12. TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation
13. Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases
14. Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
15. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
16. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo
17. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
18. Mouse Models for Atherosclerosis Research-Which Is My Line?
19. Co-repressing immunometabolic processes in atherosclerosis
20. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells
21. Implications of NAD+boosters in translational medicine
22. Deletion of fibroblast activation protein provides atheroprotection
23. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
24. Regulation of Immunometabolic Processes in Atherosclerosis and Nonalcoholic Fatty Liver Disease by Liver Receptor Homolog 1
25. Deletion of fibroblast activation protein provides atheroprotection.
26. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature
27. JCAD: from systems genetics identification to the experimental validation of a coronary artery disease risk locus
28. Mouse Models for Atherosclerosis Research—Which Is My Line?
29. Profibrotic potential of Prominin-1+ epithelial progenitor cells in pulmonary fibrosis
30. CardioPulse: Translational research in cardiovascular disease
31. Implications of NAD+ boosters in translational medicine.
32. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
33. Adipose tissue macrophage polarization in cardiovascular disease
34. Protective role of the co-stimulator CD27 receptor and regulatory T cells in early atherogenesis
35. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function
36. Neutrophils in cardiovascular disease
37. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
38. LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARγ ligand synthesis
39. LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer
40. Brain-derived neurotrophic factor Val66Met polymorphism in depression and thrombosis: SIRT1 as a possible mediator
41. Molecular basis for the regulation of the nuclear receptor LRH-1
42. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
43. SIRT1 – An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis
44. Adipose tissue macrophage polarization in cardiovascular disease.
45. Profibrotic potential of Prominin-1+epithelial progenitor cells in pulmonary fibrosis
46. Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol
47. Protective roles of SIRT1 in atherosclerosis
48. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells
49. ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
50. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.